Literature DB >> 19515585

Quantitative assessment of blood volume and permeability in cerebral mass lesions using dynamic contrast-enhanced computed tomography in the dog.

Alexander G MacLeod1, Peter J Dickinson, Richard A LeCouteur, Robert J Higgins, Rachel E Pollard.   

Abstract

RATIONALE AND
OBJECTIVES: To evaluate cerebral blood volume (CBV) and permeability (PS) in spontaneously occurring cerebral neoplastic and non-neoplastic lesions in dogs using dynamic contrast-enhanced computed tomography (DCE-CT).
MATERIALS AND METHODS: Dogs presenting with spontaneous intracranial lesions (n = 16) underwent DCE-CT at the level of the lesion followed by a histologically confirmed diagnosis from a CT-guided stereotactic biopsy. Data post-processing was performed with commercially available CT software (GEMS Advantage Workstation 4.2). Symmetric regions of interest (ROIs) were drawn within the lesion and unaffected areas on the contralateral side. Values were compared between lesion types and ratios of lesion-to-normal brain were calculated.
RESULTS: Dogs with extra-axial lesions (n = 3 meningiomas) had marked elevation of CBV and PS compared to normal brain. All Grade III gliomas (n = 5) had mildly elevated CBV and markedly elevated PS values. All lower Grade II gliomas (n = 2) had minimal elevation in CBV and PS. Dogs with non-neoplastic intra-axial lesions (one each necrotizing, fungal, and lymphoplasmacytic encephalitis) had elevation of PS with normal to mildly elevated CBV. Lesion-to-normal brain ratios for PS separated extra- and intra-axial neoplasms and intra-axial inflammatory/degenerative lesions from each other.
CONCLUSIONS: Low-grade gliomas do not consistently demonstrate elevated vascular parameters, whereas Grade III gliomas and non-neoplastic intra-axial lesions have elevated PS. Ratios between such lesions and normal brain may prove useful for differentiating types of lesions. These findings resemble those previously reported in similar lesions in people indicating that the dog may act as a good model for intracranial masses for the study of lesion angiogenesis and response to therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19515585     DOI: 10.1016/j.acra.2009.03.015

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  5 in total

Review 1.  Invited review--neuroimaging response assessment criteria for brain tumors in veterinary patients.

Authors:  John H Rossmeisl; Paulo A Garcia; Gregory B Daniel; John Daniel Bourland; Waldemar Debinski; Nikolaos Dervisis; Shawna Klahn
Journal:  Vet Radiol Ultrasound       Date:  2013-11-13       Impact factor: 1.363

Review 2.  Companion animal models of neurological disease.

Authors:  Brittanie Partridge; John H Rossmeisl
Journal:  J Neurosci Methods       Date:  2019-11-13       Impact factor: 2.390

Review 3.  Advances in diagnostic and treatment modalities for intracranial tumors.

Authors:  P J Dickinson
Journal:  J Vet Intern Med       Date:  2014-05-09       Impact factor: 3.333

4.  Perfusion and Volume Response of Canine Brain Tumors to Stereotactic Radiosurgery and Radiotherapy.

Authors:  A L Zwingenberger; R E Pollard; S L Taylor; R X Chen; J Nunley; M S Kent
Journal:  J Vet Intern Med       Date:  2016-05-05       Impact factor: 3.333

Review 5.  Canine Primary Intracranial Cancer: A Clinicopathologic and Comparative Review of Glioma, Meningioma, and Choroid Plexus Tumors.

Authors:  Andrew D Miller; C Ryan Miller; John H Rossmeisl
Journal:  Front Oncol       Date:  2019-11-08       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.